Ezetimibe (Ezetrol, Zetia)
Prescription cholesterol-lowering medicine that blocks cholesterol absorption in the intestine; can also be used with a statin.

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

DETAILED OVERVIEW
What is Ezetimibe (Ezetrol, Zetia)?
Ezetimibe, also sold as Ezetrol and Zetia, is a prescription cholesterol-lowering medicine. It is approved for high cholesterol, either on its own or together with a statin (another class of cholesterol-lowering drugs).
In the small intestine it blocks cholesterol from being absorbed from food and bile. On its own it lowers LDL (the “bad” cholesterol) by about 15–20%, which is modest, but it acts independently of statins, so the two effects add up. In a large trial, adding it to a statin after an acute heart problem led to fewer cardiovascular events. It was the first non-statin drug shown to have this benefit. It can cause digestive complaints and a mild, temporary rise in liver enzymes; muscle pain occurs mainly together with a statin. It must not be used in pregnancy or breastfeeding, or in active liver disease. With a medicine called ciclosporin it can be given only under close monitoring, because the two raise each other’s levels.
Mechanism
NPC1L1 inhibition in the small intestine: blocks absorption of dietary and biliary cholesterol.
LDL reduction
About 15-20% as monotherapy; a further substantial fall on top of a statin, because the target is independent.
Why it is a milestone
The first non-statin LDL-lowering drug with proven cardiovascular benefit
Bioavailability
Cannot be determined in absolute terms, as the compound is practically insoluble in aqueous media.
No anecdote collected yet.
Data console
Lab data
Cannon CP, Blazing MA, Giugliano RP . Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.. The New England journal of medicine.
Baigent C, Landray MJ, Reith C . The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.. Lancet (London, England).
Giugliano RP, Cannon CP, Blazing MA . Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).. Circulation.
Florentin M, Liberopoulos EN, Elisaf MS . Ezetimibe-associated adverse effects: what the clinician needs to know.. International journal of clinical practice.
Safety
Side effects, stop signs, contraindications
Side effects · 4
- Muscle pain: more frequent in combination with a statin, while as monotherapy it barely differed from placebo in trials. This is one reason it is considered an alternative in statin intolerance.
- Rising liver enzymes: usually mild and transient, more frequent in combination with a statin than alone.
- Gastrointestinal complaints: diarrhea, bloating, abdominal discomfort. Mild and usually improving with continued treatment.
- Fatigue: a less common complaint, but listed in the Florentin 2008 clinician-facing review of adverse effects.
Contraindications · 4
- Active liver disease or persistent unexplained transaminase elevation: must be clarified before starting treatment.
- Pregnancy and breastfeeding: cholesterol is essential to fetal development, so lipid-lowering treatment is contraindicated.
- In combination with a statin the statin's own contraindications apply: active liver disease, pregnancy, and the statin's own interactions.
- Ciclosporin therapy: the two raise each other's plasma levels, so co-administration requires close monitoring.
Related Pharmaceuticals
Same therapeutic category
Studies
Related research and clinical findings
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.
Cannon CP, Blazing MA, Giugliano RP
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Baigent C, Landray MJ, Reith C
Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
Giugliano RP, Cannon CP, Blazing MA
Ezetimibe-associated adverse effects: what the clinician needs to know.
Florentin M, Liberopoulos EN, Elisaf MS
Telegram
Have a question about Ezetimibe (Ezetrol, Zetia)?
Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!
Personalized consultation
Want a detailed conversation tailored to your data?
Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.
Fill out the form~5–7 min · prep questionnaire · confidential · GDPR-compliant
The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.